The HIF pathway: Implications for patterns of gene expression in cancer

Novartis Foundation Symposium

Volumn 240, Issue , 2001, Pages 212-225

  Wykoff, Charles C ^a   Pugh, Christopher W ^b   Harris, Adrian L ^a   Maxwell, Patrick H ^b   Ratcliffe, Peter J ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BHLH PAS FACTOR HLF; BHLH-PAS FACTOR HLF; DNA BINDING PROTEIN; DNA BINDING PROTEINS; ERYTHROPOIETIN; HELIX LOOP HELIX PROTEIN; HIF 1 PROTEIN; HIF-1 PROTEIN; NUCLEAR PROTEIN; TRANS ACTIVATORS; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

CELL HYPOXIA; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VON HIPPEL LINDAU DISEASE;

CELL HYPOXIA; DNA-BINDING PROTEINS; ERYTHROPOIETIN; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELIX-LOOP-HELIX MOTIFS; HIPPEL-LINDAU DISEASE; HUMAN; NEOPLASMS; NUCLEAR PROTEINS; SUPPORT, NON-U.S. GOV'T; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0038974634     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (36)

1. Bates S, Rowan S, Vousden KH 1996 Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene 13:1103-1109
2. Carmeliet P, Dor Y, Herbert JM et al 1998 Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485-90 (erratum: 1998 Nature 395:525)
3. Chazaud B, Bonavaud S, Plonquet A, Pouchelet M, Gherardi RK, Barlovatz-Meimon G 2000 Involvement of the [uPAR:uPA:PA1-I:LRP] complex in human myogenic cell motility. Exp Cell Res 258:237-244
4. Chen JS, Mehta K 1999 Tissue transglutaminase: an enzyme with a split personality. Int J Biochem Cell Biol 31:817-836
5. Cockman ME, Masson N, Mole DR et al 2000 Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275:25733-25741
6. Ebert BL, Gleadle JM, O'Rourke JF, Bartlett SM, Poulton J, Ratcliffe PJ 1995 Isoenzyme specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. Biochem J 313:809-814
7. Gnarra JR, Tory K, Weng Y et al 1994 Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7:85-90
8. Griffiths JR 1991 Are cancer cells acidic? Br J Cancer 64:425-427
9. Hahn JH, Kim MK, Choi EY et al 1997 CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J Immunol 159:2250-2258
10. Heacock CS, Sutherland RM 1990 Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism Br J Cancer 62:217-225
11. Höckel M, Knoop C, Schlenger K et al 1993 Intratumoural pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26:45-50
12. Home MC, Donaldson KL, Goolsby GL et al 1997 Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J Biol Chem 272:12650-12661
13. Ivanov SV, Kuzmin I, Wei MH et al 1998 Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 95:12596-12601
14. Kaelin WG, Maher ER 1998 The VHL tumour-suppressor gene paradigm. Trends Genet 14:423-426
15. Kietzmann T, Schmidt H, Unthan-Fechner K, Probst I, Jungermann K 1993 A ferro-heme protein senses oxygen levels, which modulate the glucagons-dependent activation of the phosphoenolpyruvate carboxykinase gene in rat hepatocyte cultures. Biochem Biophys Res Commun 195:792-798
16. Kim KJ, Li B, Winer J et al 1993 Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844
17. Koong AC, Denko NC, Hudson KM et al 2000 Candidate genes for the hypoxic tumor phenotype. Cancer Res 60:883-887
18. Levy AP, Levy NS, Wegner S, Goldberg MA 1995 Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333-13340
19. Martínez-Zaguilán R, Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix HJ 1996 Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 14:176-186
20. Maxwell PH, Pugh CW, Ratcliffe PJ 1993 Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci USA 90:2423-2427
21. Maxwell PH, Dachs GU, Gleadle JM et al 1997 Hypoxia inducible factor-1 modulates gene expression in solid tumours and influences both angiogenesis and tumour growth. Proc Natl Acad Sci USA 94:8104-8109
22. Maxwell PH, Wiesener MS, Chang GW et al 1999 The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275
23. Newell K, Franchi A, Pouysségur J, Tannock I 1993 Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity. Proc Natl Acad Sci USA 90:1127-1131
24. Ohh M, Park CW, Ivan M et al 2000 Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2:423-427
25. Parkkila S, Rajaniemi H, Parkkila AK et al 2000 Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 97:2220-2224
26. Plate KH, Breier G, Weich HA, Risau W 1992 Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848
27. Ryan HE, Lo J, Johnson RS 1998 HIF-1alpha is required for solid tumour formation and embryonic vascularization. EMBO J 17:3005-3015
28. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551-578
29. Semenza GL, Wang GL 1992 A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447-5454
30. Shweiki D, Itin A, Soffer D, Keshet E 1992 Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845
31. Strickland DK, Kounnas MZ, Argraves WS 1995 LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 9:890-898
32. Sun H, Taneja R 2000 Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Proc Natl Acad Sci USA 97:4058-4063
33. Teicher BA, Liu SD, Liu JT, Holden SA, Herman TS 1993 A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res 13:1549-1556
34. 2 tension. Proc Natl Acad Sci USA 92:5510-5514
35. Wykoff CC, Beasley NJ, Watson PH et al 2000 Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60:7075-7083
36. Yamagata M, Hasuda K, Stamato T Tannock IF 1998 The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. Br J Cancer 77:1726-1731